The COVID-19 pandemic has obviously had a very negative impact on international travel, especially non-essential travel outside of the continental United States, where traveler's diarrhea risk is greatest.

Nov 30, 2021 / receipt, needs a key / Rob, other | earnings call 2021-11-30 | transcript 47c2452d-9006-41bc-ac84-d5c1d4500121 | chars 34477-34682 | segment 34

Obviously, before I turn to Rob, the pandemic has had a very negative impact on travel to high-risk territory. Therefore, what we have seen in the beginning, right before the pandemic, with MCOLO, which was a very nice trend, has come to a halt, a complete halt almost.

Nov 30, 2021 / receipt, needs a key / Rob, other | earnings call 2021-11-30 | transcript 47c2452d-9006-41bc-ac84-d5c1d4500121 | chars 52828-53097 | segment 53

Plans are also in place to build on the initial momentum that M-Colo was generating pre-COVID travel restrictions.

Aug 26, 2021 / receipt, needs a key / Rob Jackson, other | earnings call 2021-08-26 | transcript 347d5291-3b63-4b71-ab06-dfb5e8afd288 | chars 5874-5988 | segment 5

The COVID-19 pandemic has negatively impacted international travel, especially non-essential travel outside the continental United States, where travelers' diarrhea risk is greatest.

Aug 26, 2021 / receipt, needs a key / Robbie Ben-Asher, Senior VP of Sales and Marketing | earnings call 2021-08-26 | transcript 347d5291-3b63-4b71-ab06-dfb5e8afd288 | chars 30968-31150 | segment 31

The U.S. is now emerging from the shadows of COVID-19, with patients returning to clinics and travel resuming, positively affecting also M-Colo's prospects.

May 27, 2021 / receipt, needs a key / Dror Ben Asher, CEO | earnings call 2021-05-27 | transcript 43c9b093-f635-4675-a3d4-84ac6ba2f1fa | chars 4162-4318 | segment 4

At the start of April, Red Hill resumed promotion of AMCOLO. And as the pandemic resides, travel is resuming, especially within North America, and particularly travel to Mexico. Travel to Mexico has doubled since its pandemic low last April, but it still remains about 50% below normal. International travel outside of Mexico remains even lower. Despite that, we know some intrepid travelers are determined to get away, and we are equally determined to help them enjoy the vacation by equipping savvy travelers with mColo.

May 27, 2021 / receipt, needs a key / Rob, other | earnings call 2021-05-27 | transcript 43c9b093-f635-4675-a3d4-84ac6ba2f1fa | chars 26468-26990 | segment 26

Lean commercial model - Rebyota® and Clenpiq® are expected to generate a positive cash contribution to RedHill

ir_statement / Sep 17, 2026 / receipt

Aggressive growth planned

ir_statement / Sep 17, 2026 / receipt

Stronger liquidity and a larger U.S. commercial platform position RedHill to pursue additional complementary commercial products

ir_statement / Sep 17, 2026 / receipt

Talicia® divestiture proceeds funded a larger commercial business with capacity to add more revenue-generating assets

ir_statement / Sep 17, 2026 / receipt

$12M redeployed for global Rebyota® and U.S. Clenpiq® commercialization rights from Ferring

ir_statement / Sep 17, 2026 / receipt

substantially reduced the operating cost base while maintaining core U.S. commercial capabilities

ir_statement / Sep 17, 2026 / receipt